Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis

Based on Routine Clinical Practice Inclusion criteria: * Patients affected by allergic rhinoconjunctivitis sensityzed to one or several aeroallergens.Although allergic rhinoconjunctivitis is the pathology under study, the inclusion of patients with mild concomitant asthma is allowed (GINA 2013) * Patients older than 12 years old * Patients being subsidiaries of receiving allergen immunotherapy treatment * Patients who obtained a prick test result ≥ 3 mm diameter to any aeroallergen. Positive and negative control of the test should give consistent results. * Patients with specific immunoglobulin E ≥ class 2 (CAP/PHADIA) to any aeroallergen. Exclusion criteria (based on routine clinical practice): * Patients with severe asthma or forzed expiratoy volumen in 1 second FEV1\< 70% even if the are pharmacologically controlled . * Patients with: immunological, cardiac, renal or hepatic illnesses or any other medical condition that the investigator seems relevant so as to interfere with the treatment. * Patients with a previous history of anaphylaxis * Patients under treatment with tricyclic antidepressives, phenothiazines , β-blockers, or Angiotensin Converting Enzyme Inhibitors (ACEI) * Female patients who are pregnant or breast-feeding